Description

Technical Parameters

SR9009 Raw Material Powder Core Introduction

SR9009 (Stenabolic) REV-ERBα agonist

Chemical name : (2-([1,1'-biphenyl]-4-yl)-N-(2,2-diphenylethyl)-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-3-carboxamide)

CAS No .: 1379686-29-5

Molecular formula : C₃₀H₂₅N₃O₂

Molecular weight : 459.54

Purity : ≥98% (HPLC)

Melting point : 158-162°C

Appearance : White crystalline powder

Core Effects

SR9009 is a REV-ERBα protein agonist . Due to its unique energy metabolism regulation and circadian rhythm optimization effects , it is widely used in endurance improvement, metabolic research, and athletic performance optimization .

✅ Stamina significantly improved :

Activates the REV-ERBα pathway , increasing mitochondrial biogenesis and function

Aerobic endurance increased by 40-60%, and fatigue was significantly reduced

✅ Metabolic Optimization :

Improve glucose metabolism and enhance insulin sensitivity

Promote fat oxidation and target the reduction of visceral fat

✅ Biorhythm regulation :

Optimize circadian clock gene expression and improve sleep-wake cycles

Reduce inflammation and speed up the recovery process

SR9009 features

Low oral bioavailability :

Significant first -pass effect and low oral bioavailability (<10%)

Special dosage forms are needed to improve bioavailability

Non- hormonal mechanisms :

Does not act on androgen/estrogen receptors and has no hormone-related side effects

No suppression of the HPTA axis , no need for PCT restoration

Short half-life :

Half-life is approximately 4 hours , requiring multiple daily dosing

Rapid onset and clearance , no risk of drug accumulation

End Product Preparation Guide

1. Sublingual tablet (optimal dosage form) :

Example formulation (10mg/tablet):

SR9009 raw material: 10mg

Macrogol 6000: 40 mg

Mannitol: 25 mg

Menthol: 2mg

Preparation process :

Micronization of raw materials : D90≤5μm, improving dissolution

Melt Granulation : Low-Temperature Melting Polyethylene Glycol Carrier

Tablet forming : 6mm round die, 5-8kN pressure

Aluminum foil packaging : moisture-proof and light-proof protection

2. Transdermal gel (alternative dosage form) :

Example formulation (50 mg/mL):

SR9009 raw materials: 5%

Propylene glycol: 40%

Ethanol: 30%

Carbomer: 2%

Preparation process :

Raw material dissolution : ethanol + propylene glycol mixed solvent

Gelation : Carbomer dispersion followed by neutralization

Filling : Aluminum tube or pump packaging

How to use

1. Endurance Enhancement Research :

Dosage : 20-30 mg/day, divided into 3 doses sublingually

Timing : 1 hour before training + 4 hours between two sessions

Duration : 6-8 weeks

2. Metabolic studies :

Dosage : 10-20 mg/day, divided into 2 doses sublingually

Monitoring : Glucose tolerance test + body composition analysis

3. Dosage form selection priority :

Sublingual tablets : bioavailability 20-30%

Transdermal gel : bioavailability 10-15%

Oral capsules : Bioavailability <5% (not recommended)

4. Dosage regimen :

Sublingual : Place under the tongue for 5-10 minutes

Transdermal application : Apply to the skin of the wrist or neck

3 times a day : Administer every 6-8 hours to maintain blood concentration

Why choose SR9009 raw material ?

Unique mechanism of action , non-hormonal pathway to improve endurance

Multiple metabolic benefits , simultaneously optimizing endurance and metabolic health

High scientific research value , innovative tool for biorhythm research

Quality Assurance :

GMP -compliant production , each batch HPLC purity tested (≥98% )

Third-party laboratory report (COA) is included with the product

Microbial limit testing to ensure safety

Worldwide Shipping :

Original sealed packaging , moisture-proof and light-proof

Private delivery , no logo on the outer packaging

Temperature- stable transportation to ensure product stability

Conclusion

SR9009 needs to be delivered via a sublingual tablet or transdermal gel formulation to enhance bioavailability. It is particularly suitable for studies on exercise endurance, metabolic syndrome, and biorhythm . The research dose is 20-30mg/day .

If you need anything, please contact Allen